Meeting News

Highlights from ISET: Paclitaxel controversy, LIBERTY 360° and more

The International Symposium on Endovascular Therapy featured discussions of some of the hottest topics in vascular intervention, including the possible link between mortality and paclitaxel-coated devices to treat peripheral artery disease, new data on technologies to treat PAD and critical limb ischemia, and the availability of carotid artery stents. Following are some of the highlights covered by Cardiology Today’s Intervention, which was on-site at the meeting.

ISET town hall calls attention to paclitaxel-coated devices

HOLLYWOOD, Fla. — Increased attention on the mortality risk associated with paclitaxel-coated devices used in patients with peripheral artery disease has prompted much debate in the vascular intervention community. Leaders in the area took the stage during a town hall opening session at ISET to discuss recent data and what this means for current standards of practice and further investigation.

Read More

LIBERTY 360°: Endovascular interventions improve outcomes across all Rutherford classes

HOLLYWOOD, Fla. — Treatment with FDA-approved endovascular device interventions was associated with improved clinical outcomes at 2.5-year follow-up, regardless of severity of peripheral artery disease or critical limb ischemia at baseline, according to new data from the LIBERTY 360° study.

Read More

SAVER: DCB safe, effective at 1 year in real-world population

HOLLYWOOD, Fla. — Treatment with a drug-coated balloon resulted in high rates of patency and low rates of complications at 1 year in a registry of real-world patients with peripheral artery disease.

Read More

Advancements in medical therapy provide options for patients with PAD, CLI

HOLLYWOOD, Fla. — Medical therapies for patients with peripheral artery disease and critical limb ischemia continue to improve, providing new options for treatment for this challenging patient population, Michael R. Jaff, DO, FACC, FSCAI, said during a keynote address at ISET.

Read More

IVC filter retrieval costly to hospitals

HOLLYWOOD, Fla. — Costs of inferior vena cava filter removal vary greatly, and almost all centers that perform them have a negative contribution margin, according to data presented at ISET.

Read More

Patient focus, interdisciplinary collaboration key when building a CLI team

HOLLYWOOD, Fla. — A focus on patient-centered treatment and interdisciplinary collaboration is crucial to the success of a critical limb ischemia team, Jihad A. Mustapha, MD, FACC, FSCAI, said during a presentation at ISET.

Read More

Data raise questions about expanded availability of CAS

The question of whether carotid artery stenting should be available for all patients boils down to the data, which can be cast in different lights, speakers said at ISET.

Read More

 

ZILVER PASS: DES, bypass equally effective at 1 year in long femoropopliteal lesions

HOLLYWOOD, Fla. — A drug-eluting stent conferred similar survival, patency and freedom from target lesion revascularization compared with bypass surgery in patients with long femoropopliteal lesions, according to 12-month results of the ZILVER PASS trial.

Read More

Increased hydration may improve symptoms of claudication, rest pain

HOLLYWOOD, Fla. — Among patients with claudication with or without pain at rest who did not respond to medical therapy, a strategy of increasing water consumption to more than 2.5 L per day improved symptoms, according to research presented at ISET.

Read More

COMPARE Pilot: No difference between two DCBs in 2-year patency

HOLLYWOOD, Fla. — Two-year results from the first 150 patients in the COMPARE Pilot study show similar patency with two drug-coated balloons for the treatment of patients with symptomatic peripheral artery disease.

Read More

 

 

 

 

The International Symposium on Endovascular Therapy featured discussions of some of the hottest topics in vascular intervention, including the possible link between mortality and paclitaxel-coated devices to treat peripheral artery disease, new data on technologies to treat PAD and critical limb ischemia, and the availability of carotid artery stents. Following are some of the highlights covered by Cardiology Today’s Intervention, which was on-site at the meeting.

ISET town hall calls attention to paclitaxel-coated devices

HOLLYWOOD, Fla. — Increased attention on the mortality risk associated with paclitaxel-coated devices used in patients with peripheral artery disease has prompted much debate in the vascular intervention community. Leaders in the area took the stage during a town hall opening session at ISET to discuss recent data and what this means for current standards of practice and further investigation.

Read More

LIBERTY 360°: Endovascular interventions improve outcomes across all Rutherford classes

HOLLYWOOD, Fla. — Treatment with FDA-approved endovascular device interventions was associated with improved clinical outcomes at 2.5-year follow-up, regardless of severity of peripheral artery disease or critical limb ischemia at baseline, according to new data from the LIBERTY 360° study.

Read More

SAVER: DCB safe, effective at 1 year in real-world population

HOLLYWOOD, Fla. — Treatment with a drug-coated balloon resulted in high rates of patency and low rates of complications at 1 year in a registry of real-world patients with peripheral artery disease.

Read More

Advancements in medical therapy provide options for patients with PAD, CLI

HOLLYWOOD, Fla. — Medical therapies for patients with peripheral artery disease and critical limb ischemia continue to improve, providing new options for treatment for this challenging patient population, Michael R. Jaff, DO, FACC, FSCAI, said during a keynote address at ISET.

Read More

IVC filter retrieval costly to hospitals

HOLLYWOOD, Fla. — Costs of inferior vena cava filter removal vary greatly, and almost all centers that perform them have a negative contribution margin, according to data presented at ISET.

Read More

Patient focus, interdisciplinary collaboration key when building a CLI team

HOLLYWOOD, Fla. — A focus on patient-centered treatment and interdisciplinary collaboration is crucial to the success of a critical limb ischemia team, Jihad A. Mustapha, MD, FACC, FSCAI, said during a presentation at ISET.

Read More

PAGE BREAK

Data raise questions about expanded availability of CAS

The question of whether carotid artery stenting should be available for all patients boils down to the data, which can be cast in different lights, speakers said at ISET.

Read More

 

ZILVER PASS: DES, bypass equally effective at 1 year in long femoropopliteal lesions

HOLLYWOOD, Fla. — A drug-eluting stent conferred similar survival, patency and freedom from target lesion revascularization compared with bypass surgery in patients with long femoropopliteal lesions, according to 12-month results of the ZILVER PASS trial.

Read More

Increased hydration may improve symptoms of claudication, rest pain

HOLLYWOOD, Fla. — Among patients with claudication with or without pain at rest who did not respond to medical therapy, a strategy of increasing water consumption to more than 2.5 L per day improved symptoms, according to research presented at ISET.

Read More

COMPARE Pilot: No difference between two DCBs in 2-year patency

HOLLYWOOD, Fla. — Two-year results from the first 150 patients in the COMPARE Pilot study show similar patency with two drug-coated balloons for the treatment of patients with symptomatic peripheral artery disease.

Read More

 

 

 

 

    See more from International Symposium on Endovascular Therapy